Kuala Lumpur, 4 December 2019 – Novartis Malaysia, a global leader in the healthcare space has been awarded the Top Employer for 2020. A highly sought after recognition, this certificate was given by the independent Top Employers Institute, a global company which recognizes excellence in people practices.
“We are honoured to receive this recognition by an independent party as it reaffirms Novartis Malaysia’s continuous commitment to provide the best working environment for our associates with continues improvement in human resources policy, our benefits and career development opportunities.” said Patrik Grande, President & Managing Director, Novartis Malaysia. “At Novartis Malaysia, we believe in an inspired, curious and unboss culture to unleash the power of our people. We take pride ourselves for embracing Diversity & Inclusion Initiatives, attracting and developing talents from diverse backgrounds towards our mission to reimagine medicines.”
Anne Heng, People & Organization Head, Novartis Malaysia said, “As part of our commitment to always place our associates at the forefront, we are introducing a new parental leave policy, offering equal parental leave to all parents through birth, surrogacy or adoption. This global policy which will take effect by 1st January 2020 offers 14 weeks (3.4 months) fully paid parental leave.
“At Novartis, balance is at the core of our Diversity &Inclusion where we ensure our associates are privy to both work life and gender balance. We celebrate life and recognize moments that matter. One of the most life changing moments our associates experience is becoming a parent and welcoming new life into their lives. Thus, we want to celebrate this occasion with our associates.
“We also aim to support our associates’ journey towards becoming new parents with our new leave policy. As gender equity is a priority at Novartis, we want the men in our company to feel empowered to share childcare responsibility.”
Novartis is reimagining medicine to improve and extend people’s lives. Our divisions; Innovative Medicines and Sandoz are supported by functional organizations with global scale. Our Innovative Medicines Division is made up of two Business Units; Novartis Pharmaceuticals and Novartis Oncology Division which commercializes innovative-patented medicines to enhance health outcomes for patients and healthcare professionals. Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
Novartis Malaysia has been present in Malaysia since the early 1970’s. Following the merger of Sandoz & Ciba-Geigy, Novartis was formed 1996. In 2015, Kuala Lumpur was chosen as one of the five Novartis Global Service Centers, which delivers a broad variety of services to the Novartis group of companies worldwide. The others are located in Asia, Europe and Latin America. Services offered by Novartis Global Service Center Kuala Lumpur include IT, HR Services, FRA Operations, Product Lifecycle Services and Procurement.